- Exchange: Tokyo
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Mebiopharm Co Ltd (4580)
| Open: | - | Day's Range: | - | Volume: | 18,900 |
|---|---|---|---|---|---|
| Previous Close: | 38 | 52wk Range: | 30 - 50 | 1-Yr Rtn: | - |
Key Statistics for 4580
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. TPX | - |
| Earnings Per Share (ttm) | -75.0000 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M JPY) | 124.48 |
| Shares Outstanding (M) | 3.28 |
| 30 Day Average Volume | 2,633 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | 0.7284 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 06/07/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4580
No data available
Company Profile & Key Executives for 4580
MEBIOPHARM CO LTD. researches and develops a variety of pharmaceuticals which are still in pipe lines. The company also performs consulting works for new medical markets.
| Tadashi FujisawaFounder/President/CEO | Kazuo MaruyamaDirector |
| Naoyuki MorisakiDirector | Kazushi OkadaDirector |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
4580 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page